Valuation: DexCom, Inc.

Market Cap 3.17TCr 2.83TCr 2.64TCr 2.4TCr 4.53TCr 3,07200Cr 4.55TCr 32TCr 12TCr 1,56600Cr 12TCr 12TCr 5,02600Cr P/E 2026 *
33.8x
P/E 2027 * 28.5x
Enterprise Value 3.1TCr 2.77TCr 2.57TCr 2.34TCr 4.42TCr 2,99800Cr 4.44TCr 31TCr 12TCr 1,52900Cr 12TCr 11TCr 4,90500Cr EV / Sales 2026 *
5.92x
EV / Sales 2027 * 5.29x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 week-1.53%
Current month-2.59%
1 month+0.20%
3 months+15.18%
6 months+28.01%
Current year+26.68%
1 week 82.92
Extreme 82.92
87.11
1 month 82.88
Extreme 82.88
90.36
3 years 54.12
Extreme 54.12
141.7
5 years 18.1
Extreme 18.096875
164.61
10 years 10.66
Extreme 10.655
164.61
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-0.42%-1.53%+23.57%+1.25% 3.17TCr
+1.13%+2.15%-24.87%+2.09% 17TCr
+0.83%+2.43%-7.30%+16.15% 11TCr
+0.13%+0.69%-23.94%+1.05% 11TCr
+2.34%+2.49%-46.47%-11.84% 7.53TCr
+0.78%+4.79%+1.84%+72.29% 6.18TCr
+0.12%+3.62%+15.06%+65.87% 5.29TCr
+0.55%+3.93%-1.51%-31.24% 5.01TCr
+0.95%-0.08%-15.93%+14.93% 4.08TCr
+1.45%+1.83% - - 3.18TCr
Average +0.92%+2.31%-8.84%+14.51% 7.83TCr
Weighted average by Cap. +0.92%+2.24%-14.51%+11.99%

Financials

2026 *2027 *
Net sales 523.01Cr 467.1Cr 434.52Cr 395.24Cr 746.25Cr 51TCr 749.48Cr 5.23TCr 2.05TCr 26TCr 1.96TCr 1.92TCr 83TCr 579.98Cr 517.98Cr 481.86Cr 438.29Cr 827.54Cr 56TCr 831.12Cr 5.8TCr 2.27TCr 29TCr 2.18TCr 2.13TCr 92TCr
Net income 97Cr 87Cr 81Cr 74Cr 139.02Cr 9.43TCr 139.62Cr 974.28Cr 381.74Cr 4.81TCr 365.89Cr 357.89Cr 15TCr 114.89Cr 102.61Cr 95Cr 87Cr 163.94Cr 11TCr 164.64Cr 1.15TCr 450.15Cr 5.67TCr 431.45Cr 422.02Cr 18TCr
Net Debt -76Cr -68Cr -63Cr -58Cr -108.6Cr -7.37TCr -109.07Cr -761.08Cr -298.21Cr -3.76TCr -285.82Cr -279.57Cr -12TCr -106.15Cr -95Cr -88Cr -80Cr -151.45Cr -10TCr -152.11Cr -1.06TCr -415.88Cr -5.24TCr -398.61Cr -389.89Cr -17TCr
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
-
Date Price Change
09/26/09 $84.08 -0.42%
08/26/08 $84.44 +0.16%
07/26/07 $84.30 +1.10%
06/26/06 $83.38 -4.08%
05/26/05 $86.93 +1.81%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
84.11USD
Average target price
96.23USD
Spread / Average Target
+14.41%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DexCom, Inc.